Lamellar pathology in horses with pituitary pars intermedia dysfunction.

REASONS FOR PERFORMING STUDY Hoof lamellar pathology in horses with pituitary pars intermedia dysfunction (PPID) has not been described previously. OBJECTIVES To describe the histomorphometry and pathological lesions in hoof lamellar tissue of animals that had PPID with or without concurrent laminitis, with reference to age-matched controls. We hypothesised that lamellar lesions consistent with laminitis would be associated with PPID, even in animals without current or historical laminitis. STUDY DESIGN Prospective case-control study. METHODS Mid-dorsal hoof histological sections were obtained post mortem from the forelimbs of 16 PPID-affected animals either with (n = 6) or without laminitis (n = 10) and 10 age- and breed-matched controls. Sections were examined by a blinded veterinary pathologist. The length and width of 10 primary epidermal lamellae were measured using image analysis software. The morphology and pathology of primary and secondary epidermal lamellae were then typed or graded in axial, middle and abaxial regions. Fasting serum insulin, plasma adrenocorticotropin and blood glucose concentration were measured from blood samples taken prior to euthanasia. RESULTS All animals with PPID and laminitis had fasting hyperinsulinaemia (median 74.1 miu/l, interquartile range 49.9-349.5 miu/l) whereas PPID animals without laminitis had serum insulin concentrations below the upper limit of the reference range (<20 miu/l). Lamellar pathology in PPID animals with laminitis was variable in severity and unrelated to the reported duration of laminitis (range 2 months-5 years). Most lesions were located abaxially within the lamellar tissue and included increased length and width of the lamellae, chronic abnormal keratinisation, interlamellar epidermal bridging and cell death with more acute lamellar tearing in some cases. The lamellae of PPID animals without laminitis were normal referent to the relevant control group. CONCLUSIONS Whether PPID and hyperinsulinaemia have a causal inter-relationship or not, it may only be the hyperinsulinaemia that is associated with lamellar morphological alteration and pathology consistent with laminitis.

[1]  N. Karikoski,et al.  Pathology of Natural Cases of Equine Endocrinopathic Laminitis Associated With Hyperinsulinemia , 2015, Veterinary pathology.

[2]  C. McGowan,et al.  Prevalence and risk factors for hyperinsulinaemia in ponies in Queensland, Australia. , 2014, Australian veterinary journal.

[3]  N. Karikoski,et al.  Morphological and cellular changes in secondary epidermal laminae of horses with insulin-induced laminitis. , 2014, American journal of veterinary research.

[4]  E. Tadros,et al.  Insulin dysregulation. , 2014, Equine veterinary journal.

[5]  C. McGowan,et al.  Prevalence, risk factors and clinical signs predictive for equine pituitary pars intermedia dysfunction in aged horses. , 2013, Equine veterinary journal.

[6]  V. Copas,et al.  Circannual variation in plasma adrenocorticotropic hormone concentrations in the UK in normal horses and ponies, and those with pituitary pars intermedia dysfunction. , 2012, Equine veterinary journal.

[7]  A. V. van Eps,et al.  Equine laminitis: comparative histopathology 48 hours after experimental induction with insulin or alimentary oligofructose in standardbred horses. , 2011, Journal of comparative pathology.

[8]  N. Karikoski,et al.  The prevalence of endocrinopathic laminitis among horses presented for laminitis at a first-opinion/referral equine hospital. , 2011, Domestic animal endocrinology.

[9]  D. McFarlane Equine pituitary pars intermedia dysfunction. , 2011, The Veterinary clinics of North America. Equine practice.

[10]  N. Frank Equine metabolic syndrome. , 2009, The Veterinary clinics of North America. Equine practice.

[11]  C. Pollitt,et al.  Histopathology of insulin-induced laminitis in ponies. , 2010, Equine veterinary journal.

[12]  R. Eustace Clinical presentation, diagnosis, and prognosis of chronic laminitis in Europe. , 2010, The Veterinary clinics of North America. Equine practice.

[13]  R. Geor,et al.  Equine metabolic syndrome. , 2010, Journal of veterinary internal medicine.

[14]  C. Pollitt,et al.  Equine laminitis: induced by 48 h hyperinsulinaemia in Standardbred horses. , 2010, Equine veterinary journal.

[15]  K. Matsuda,et al.  Histologic evaluation of the diversity of epidermal laminae in hooves of horses without clinical signs of laminitis. , 2009, American journal of veterinary research.

[16]  L. Douglass,et al.  Prediction of incipient pasture-associated laminitis from hyperinsulinaemia, hyperleptinaemia and generalised and localised obesity in a cohort of ponies. , 2009, Equine veterinary journal.

[17]  M. Miller,et al.  Correlation of Pituitary Histomorphometry with Adrenocorticotrophic Hormone Response to Domperidone Administration in the Diagnosis of Equine Pituitary Pars Intermedia Dysfunction , 2008, Veterinary pathology.

[18]  C. Pollitt,et al.  Induction of laminitis by prolonged hyperinsulinaemia in clinically normal ponies. , 2007, Veterinary journal.

[19]  R. Donnell,et al.  Evaluation of the combined dexamethasone suppression/ thyrotropin-releasing hormone stimulation test for detection of pars intermedia pituitary adenomas in horses. , 2006, Journal of veterinary internal medicine.

[20]  K. Treiber,et al.  Evaluation of genetic and metabolic predispositions and nutritional risk factors for pasture-associated laminitis in ponies. , 2006, Journal of the American Veterinary Medical Association.

[21]  V. Ganjam,et al.  Cushing's syndromes, insulin resistance and endocrinopathic laminitis. , 2010, Equine veterinary journal.

[22]  J. Beech,et al.  Evaluation of suspected pituitary pars intermedia dysfunction in horses with laminitis. , 2004, Journal of the American Veterinary Medical Association.

[23]  C. McGowan,et al.  Efficacy of trilostane for the treatment of equine Cushing's syndrome. , 2010, Equine veterinary journal.

[24]  H. Schott Pituitary pars intermedia dysfunction: equine Cushing's disease. , 2002, The Veterinary clinics of North America. Equine practice.

[25]  J. Oliver,et al.  Results of a combined dexamethasone suppression/thyrotropin-releasing hormone stimulation test in healthy horses and horses suspected to have a pars intermedia pituitary adenoma. , 1997, Journal of the American Veterinary Medical Association.

[26]  C. Pollitt Basement membrane pathology: a feature of acute equine laminitis. , 1996, Equine veterinary journal.

[27]  J. Knoll,et al.  Plasma adrenocorticotropin concentration in healthy horses and in horses with clinical signs of hyperadrenocorticism. , 1996, Journal of veterinary internal medicine.

[28]  S. Love,et al.  Diagnosis of hyperadrenocorticism in the horse , 1992 .

[29]  P. Huntington,et al.  Body condition scoring and weight estimation of horses. , 1988, Equine veterinary journal.